Home > PB Ratio > CIPLA

CIPLA
PB (Price/Book ) Ratio

The Current P/B Ratio of CIPLA is 4.65.

Share Price ₹1,345.4Apr 19,2024
Market Cap ₹108,623.6 Cr
Book Value₹23,346.0 CrMar2023 - Consolidated Results
Price/Book 4.65xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals

Definition & Calculation of PB (Price/Book ) ratio of CIPLA

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of CIPLA is calculated as :

Current Market Cap [ ₹108,623.6 Cr] as on Apr 19,2024

(/) Book Value [ ₹23,346.0 Cr] based on Mar2023 - Consolidated Results

(=) P/B Ratio [ 4.65x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for CIPLA , the investors are currently willing to pay '4.65 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CIPLA !

The chart below summarizes the trend in P/B Ratio of CIPLA over the last five years.

Historical PB (Price/Book ) ratio chart of CIPLA


PB Ratio Performance Analysis for CIPLA

- CIPLA 's latest p/b ratio is 4.65x.

- CIPLA 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 3.14x.

- CIPLA 's operated at median p/b ratio of 3.11x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CIPLA 's p/b ratio peaked in Mar2022 at 3.95x.

- CIPLA 's p/b ratio hit its five-year low in Mar2020 of 2.17x.


How does CIPLA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
CIPLA 23,346.004.65108,623.6
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.52365,311.0
DR REDDYS LABORATORIES LTD23,140.404.2899,134.3
ZYDUS LIFESCIENCES LTD17,515.805.3092,794.9
DIVIS LABORATORIES LTD12,767.107.6397,408.4
MANKIND PHARMA LTD7,435.1612.5893,565.4
TORRENT PHARMACEUTICALS LTD6,198.0713.8585,858.5
LUPIN LTD12,315.605.7270,506.8
AUROBINDO PHARMA LTD26,839.802.3763,697.4
ABBOTT INDIA LTD3,146.0217.6555,528.4
ALKEM LABORATORIES LTD9,044.696.0955,102.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CIPLA 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.37x
Max industry PB 17.65x
Median industry PB 6.09x
Average industry PB 7.88x



You may also like the below Video Courses